René Russo
Fortune : 208 016 $ au 31/08/2026
Fortune : 208 016 $ au 31/08/2026
Fondateur d'Adagio Therapeutics, Inc. René Russo occupe actuellement le poste de président du conseil d'administration d'Adagio Therapeutics, Inc. et de président, directeur général et administrateur de Xilio Therapeutics, Inc. Le Dr Russo est également membre du conseil d'administration de Celsius Therapeutics, Inc. et de X4 Pharmaceuticals, Inc. (ancien président, chef de la direction et directeur). Dans sa carrière antérieure, le Dr Russo a été directeur chez Arsanis, Inc. et vice-président des affaires médicales mondiales chez Cubist Pharmaceuticals LLC. René Russo a obtenu un doctorat et un diplôme de premier cycle de la Rutgers Business School.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
XILIO THERAPEUTICS INC 0,39 % | 15/04/2026 | 23 242 ( 0,39 % ) | 208 016 $ | 31/08/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| XILIO THERAPEUTICS, INC. | Directeur Général | 22/05/2019 |
Celsius Therapeutics, Inc.
Celsius Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops therapeutics and medicines for inflammatory diseases | Directeur/Membre du Conseil | 01/05/2020 |
Xilio Therapeutics LLC
Xilio Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops cancer biopharmaceuticals | Directeur Général | - |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Consultant / Advisor | - |
Life Science Cares, Inc. | Directeur/Membre du Conseil | - |
Leyden Laboratories B.V.
Leyden Laboratories B.V. Pharmaceuticals: MajorHealth Technology Develops nasal sprays containing antibodies that target respiratory viruses | Directeur/Membre du Conseil | - |
The Boston Ballet, Inc.
The Boston Ballet, Inc. Media ConglomeratesConsumer Services Operates as an professional classical ballet company | Directeur/Membre du Conseil | - |
Tufts Medical Center, Inc.
Tufts Medical Center, Inc. Hospital/Nursing ManagementHealth Services Offers academic medicine and research services | Directeur/Membre du Conseil | - |
| Sociétés | Poste | Fin |
|---|---|---|
| INVIVYD, INC. | Fondateur | 01/07/2022 |
| ░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 13 |
|---|---|
Cubist Pharmaceuticals LLC
Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in research, development and commercialization of pharmaceutical products | Health Technology |
Arsanis, Inc.
Arsanis, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which engages in developing human antibodies for treating infectious diseases | Health Technology |
Atlas Venture Advisors, Inc.
Atlas Venture Advisors, Inc. Investment ManagersFinance Atlas Venture Advisors invests in companies located in the United States. The firm focuses on life sciences and biotech sectors. It provides financing for early stage capital requirements. | Finance |
Tufts Medical Center, Inc.
Tufts Medical Center, Inc. Hospital/Nursing ManagementHealth Services Offers academic medicine and research services | Health Services |
The Boston Ballet, Inc.
The Boston Ballet, Inc. Media ConglomeratesConsumer Services Operates as an professional classical ballet company | Consumer Services |
Rutgers Business School
Rutgers Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xilio Therapeutics, Inc.
Xilio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops tumor-selective immuno-oncology therapies | Health Technology |
Celsius Therapeutics, Inc.
Celsius Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that develops therapeutics and medicines for inflammatory diseases | Health Technology |
X4 Pharmaceuticals, Inc.
X4 Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which engages in developing human antibodies for treating infectious diseases | Health Technology |
Invivyd, Inc.
Invivyd, Inc. BiotechnologyHealth Technology Develops antibody-based solutions for infectious diseases | Health Technology |
Life Science Cares, Inc. | |
Leyden Laboratories B.V.
Leyden Laboratories B.V. Pharmaceuticals: MajorHealth Technology Develops nasal sprays containing antibodies that target respiratory viruses | Health Technology |
Xilio Therapeutics LLC
Xilio Therapeutics LLC Pharmaceuticals: MajorHealth Technology Develops cancer biopharmaceuticals | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national